Ding Yu, Pan Yinghua, Liu Shan, Jiang Feng, Jiao Junbo
a Department of Reproductive Medicine , The Affiliated Hospital of Qingdao University , Qingdao , Shandong , China.
b Department of Radiology , Yuhuangding Hospital of Yantai , Yantai , Shandong , China.
Cancer Biol Ther. 2017 Jun 3;18(6):414-424. doi: 10.1080/15384047.2017.1323585. Epub 2017 Jun 14.
MicroRNAs had been proved to be pivotal regulators in nasopharyngeal carcinoma (NPC) by regulating a large amount of genes' expression. In our research, we aim to explore the functions of miR-9-3p on the metastases of NPC and figure out the potential mechanisms. First, we revealed downregulation of miR-9-3p and upregulation of fibronectin 1 (FN1), β1 integrin (ITGB1) and α5 integrin (ITGAV) expression in NPC tissues and cells compared with the normal using RNA-seq analysis, RT-qPCR, western blot and immunohistochemistry. By transfection of miR-9-3p mimics in CNE-1, CNE-2 and HONE-1 cells, we confirmed tumor-suppressing roles of miR-9-3p via suppressing EMT process by MTT, wound scratch, transwell assay and western blot. After constructing luciferase reporting plasmids and transient transfection in HEK 293T cells, we proved that FN1, ITGB1 and ITGAV were all targets of miR-9-3p. Then we manipulated the expression of miR-9-3p, FN1, ITGB1 and ITGAV in HONE-1 cells, verifying the tumor-promoting effect of FN1, ITGB1 and ITGAV on cell proliferation and metastases via facilitating EMT process of cells. Additionally, these functions of FN1, ITGB1 and ITGAV could be efficiently abrogated by overexpression of miR-9-3p. Taken together, we demonstrated that elevation of miR-9-3p suppresses the proliferation and metastases of NPC via downregulating FN1, ITGB1, ITGAV and inhibiting the EMT process, which provided a series of therapeutic targets for the treatment of NPC.
微小RNA已被证明通过调节大量基因的表达,在鼻咽癌(NPC)中起关键调节作用。在我们的研究中,我们旨在探索miR-9-3p在NPC转移中的功能,并找出潜在机制。首先,通过RNA测序分析、逆转录-定量聚合酶链反应(RT-qPCR)、蛋白质免疫印迹和免疫组织化学,我们发现与正常组织和细胞相比,NPC组织和细胞中miR-9-3p表达下调,纤连蛋白1(FN1)、β1整合素(ITGB1)和α5整合素(ITGAV)表达上调。通过在CNE-1、CNE-2和HONE-1细胞中转染miR-9-3p模拟物,我们通过MTT法、划痕实验、Transwell实验和蛋白质免疫印迹证实了miR-9-3p通过抑制上皮-间质转化(EMT)过程发挥肿瘤抑制作用。构建荧光素酶报告质粒并在人胚肾293T细胞中瞬时转染后,我们证明FN1、ITGB1和ITGAV均为miR-9-3p的靶标。然后我们在HONE-1细胞中调控miR-9-3p、FN1、ITGB1和ITGAV的表达,证实FN1、ITGB1和ITGAV通过促进细胞的EMT过程对细胞增殖和转移具有促肿瘤作用。此外,miR-9-3p过表达可有效消除FN1、ITGB1和ITGAV的这些功能。综上所述,我们证明miR-9-3p的升高通过下调FN1、ITGB1、ITGAV并抑制EMT过程来抑制NPC的增殖和转移,这为NPC的治疗提供了一系列治疗靶点。